Cloud Clever Administration – Digital Journal


This press release was originally distributed by ReleaseWire

Zhongshan, China – (ReleaseWire) – 7/1/2021 – On June 8, 2021, Transtek hosted a kick-off meeting for the ERP project to encourage the creation of a business ecosystem based on the collaboration of multiple partners. To achieve Transtek’s business strategy —— Products + Services. At this meeting, 5 key strategies will be proposed:

1. Organize the business system
2. Achieve an integrated business
3. Improve the accuracy of financial accounting and cost control
4. Develop effective business decision-making skills
5. Build continuous business management ability

Promote the digital transformation of Transtek business management and ensure its rapid and steady development. This kick-off meeting comprehensively planned the digital development of Transtek’s future business.

Transtek was founded in 2002 and has focused on telehealth management. They focus on providing customers with health IoT and telehealth management solutions for sports health and chronic management. Today Transtek has the most comprehensive line of multi-dimensional sign monitoring in the IoT area. Products include a cellular blood pressure monitor, a smart scale, and a blood glucose meter. Smart wearable products include fitness trackers, smartwatches, TWS earphones, etc. In addition, Transtek actively develops remote patient monitoring and works with professional organizations such as medical care, insurance, health products and health management.

Transtek is the leading brand of RPM devices in China. Based on its unique advantages in terms of innovative research and development capabilities and application technology, Transtek has established stable collaborative relationships with many world-class giants in the telemedicine management industry. Total annual sales of smart health products exceed 10 million. According to customs statistics in 2019, the total export volume of Transtek electronics products is second in China and the export volume of blood pressure monitors is third in China. Their products are widely sold to more than 50 countries and regions.

Transtek has the extensive use of Remote Patient Monitoring (RPM), which focuses on the area of ​​chronic disease management, and offers its customers a total RPM solution that integrates intelligent health hardware + SaaS + medical services. Transtek integrates health IoT, AI data, medical care and partners with medical experts to generate a wealth of evidence-based medical research. Developing intelligent health modules through research such as software and hardware integrated remote monitoring, aerobic health plans, disease risk assessment systems, etc. It further enhances Transtek’s core competencies in medicine and healthcare. At the same time, it is working with well-known medical institutions like the Shenzhen Luohu Hospital Group to build a chronic disease management foundation that will benefit thousands of households.

About Transtek
Transtek invests heavily in research and development that focuses on technological innovation to further expand our competitive advantage. Transtek has integrated resources and created a “Concept-to-Volume” platform. It is a platform developed to provide high quality medical and healthcare technology product design, solution and manufacturing services to world-class brands.

R&D ability
With 5 research laboratories and more than 400 research employees, Transtek invests massively in research and development and uses technology and product innovations to further expand our competitive advantage.

Transtek has integrated resources and created a “Concept-to-Volume” platform. The platform is designed to provide high quality design, solution and manufacturing service to customers.

Transtek is a top-class OEM / ODM / JDM manufacturer, well-known for its quality and design, which made it World No.1 Wighing Scale Manufacturer and China No.2 Wearables in 2017.

Investor Relations
Transtek is a publicly traded company with a market capitalization of $ 700 million, its share (code: was listed on the GEM of the Shenzhen Stock Exchange in 2016, also doing well so far.

Advertising. Scroll to read on.

For more information about this press release, please visit: